ethosuximide has been researched along with levetiracetam in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.17) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (15.22) | 29.6817 |
| 2010's | 29 (63.04) | 24.3611 |
| 2020's | 9 (19.57) | 2.80 |
| Authors | Studies |
|---|---|
| Brenneman, D; Cuyckens, F; Finley, MF; Herb, M; Huang, Y; Iannucci, R; Klein, B; Leclercq, L; Liu, Y; Lubin, ML; Malatynska, E; Maryanoff, BE; McComsey, DF; Milewski, ME; Parker, MH; Qin, N; Reitz, AB; Smith-Swintosky, VL; White, HS | 1 |
| Chodkowski, A; Dawidowski, M; Herold, F; Kleps, J; Szulczyk, P; Wilczek, M | 1 |
| Byrtus, H; Czopek, A; Kamiński, K; Obniska, J; Pawłowski, M | 1 |
| Kamiński, K; Obniska, J; Rzepka, S | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chlebek, I; Kamiński, K; Obniska, J; Rzepka, S; Wiklik, B | 1 |
| Dawidowski, M; Kubica, K; Skolmowski, M; Turło, J; Wilczek, M | 1 |
| Chońska, J; Dawidowski, M; Mika, W; Turło, J | 1 |
| Baker, MT; Mishra, RK | 1 |
| Andres-Mach, M; Kamiński, K; Kieć-Kononowicz, K; Latacz, G; Rapacz, A; Zagaja, M; Łuszczki, JJ | 1 |
| Abram, M; Andres-Mach, M; Kamiński, K; Obniska, J; Rapacz, A; Zagaja, M; Łuszczki, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Góra, M; Kamiński, K; Obniska, J; Rapacz, A; Rybka, S; Sałat, K; Żmudzki, P | 1 |
| Filipek, B; Furgała, A; Obniska, J; Rapacz, A; Rybka, S; Żmudzki, P | 1 |
| Filipek, B; Kamiński, K; Obniska, J; Rapacz, A | 1 |
| Filipek, B; Obniska, J; Rapacz, A; Rybka, S; Żmudzki, P | 1 |
| Concepcion, GP; Haygood, MG; Light, A; Lin, Z; Olivera, BM; Schmidt, EW; Smith, MD | 1 |
| Ottonello, D; Perria, B; Rosadini, G; Sannita, WG; Timitilli, C | 1 |
| Rekling, JC | 1 |
| Krämer, G; Kröll-Seger, J; Mothersill, IW; Novak, S; Sälke-Kellermann, RA | 1 |
| Feucht, M; Hall, RE; Kindler, J; Mayer, H; Pahs, G; Plattner, B; Steiner, H; Williams, RP | 1 |
| Bortolato, M; Fà, M; Frau, R; Marrosu, F; Mereu, G; Muroni, A; Orrù, M; Puligheddu, M; Tuveri, A | 1 |
| Bergqvist, AGC; Kilaru, S | 1 |
| Andres-Mach, MM; Czuczwar, SJ; Dudra-Jastrzebska, M; Luszczki, JJ; Patsalos, PN; Ratnaraj, N | 1 |
| Citraro, R; Constanti, A; De Fazio, S; De Sarro, G; Di Paola, ED; Russo, E; Scicchitano, F | 1 |
| Citraro, R; Constanti, A; De Fazio, S; De Sarro, G; Di Paola, ED; Perrota, I; Perrotta, I; Russo, E; Scicchitano, F | 1 |
| Carvalho, KS; Farooque, P; Goraya, J; Hardison, HH; Khurana, DS; Legido, A; Valencia, I | 1 |
| Buchneva, IA; Ermakov, AIu; Ermolenko, NA; Voronkova, KV | 1 |
| Aoto, T; Baulac, S; Boillot, M; Fumoto, N; Ikeda, A; Ishida, S; Kuwamura, M; LeGuern, E; Mashimo, T; Ohno, Y; Serikawa, T; Takahashi, R; Takizawa, A; Ueda, M | 1 |
| Buchneva, IA; Ermakov, AIu; Ermolenko, NA; Voronkova, KV; Zakharova, EI | 1 |
| Buchneva, IA; Ermakov, AIu; Ermolenko, NA; Kalikina, TA; Zakharova, EI | 1 |
| Jin, DI; Kang, JW; Lee, JE; Lee, SH; Lin, T | 1 |
| Beker van Woudenberg, A; Bouma, M; de Groot, D; Hermsen, S; Menke, A; Piersma, A; Rijkmans, E; Snel, C; Wolterbeek, A | 1 |
| Bastin, ML; Cook, AM; Oyler, DR; Smetana, KS | 1 |
| Crescioli, G; De Masi, S; Guerrini, R; Ilvento, L; Lucenteforte, E; McGreevy, KS; Mugelli, A; Pugi, A; Rosati, A; Virgili, G | 1 |
| Caro, C; Citraro, R; Constanti, A; Iannone, M; Leo, A; Nesci, V; Palma, E; Russo, E; Sarro, G; Tallarico, M | 1 |
| Abram, M; Andres-Mach, M; Esguerra, CV; Gawel, K; Jakubiec, M; Kamiński, K; Latacz, G; Lubelska, A; Nieoczym, D; Pieróg, M; Rapacz, A; Socała, K; Szewczyk, A; Szulczyk, B; Wlaź, P; Zagaja, M; Łuszczki, JJ | 1 |
| Abram, M; Andres-Mach, M; Kaminski, K; Luszczki, J; Maj, M; Rola, R; Szewczyk, A; Zagaja, M | 1 |
| Gureviciene, I; Jin, N; Tanila, H; Ziyatdinova, S | 1 |
| Coppola, G; Di Bonaventura, C; Donadio, S; Operto, FF; Padovano, C; Pastorino, GMG; Scuoppo, C; Vivenzio, V | 1 |
| Samanta, D | 1 |
| Bobylova, MY; Glukhova, LY; Kuzmich, GV; Mukhin, KY; Pylayeva, OA | 1 |
| Battino, D; Bromley, R; Kochen, S; Meador, KJ; Pennell, PB; Thomas, SV; Tomson, T | 1 |
| Schubert-Bast, S; Strzelczyk, A | 1 |
| Chu, H; Shi, J; Yang, X; Zhang, X; Zhou, Z | 1 |
6 review(s) available for ethosuximide and levetiracetam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy.
Topics: Acetamides; Acute Kidney Injury; Amines; Anticonvulsants; Carbamates; Critical Illness; Cyclohexanecarboxylic Acids; Dibenzazepines; Dose-Response Relationship, Drug; Ethosuximide; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lacosamide; Lamotrigine; Levetiracetam; Phenobarbital; Phenylcarbamates; Phenylenediamines; Phenytoin; Piracetam; Propylene Glycols; Renal Dialysis; Renal Replacement Therapy; Seizures; Topiramate; Triazines; Valproic Acid; Zonisamide | 2016 |
Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Ethosuximide; Hormones; Humans; Infant; Lamotrigine; Levetiracetam; Network Meta-Analysis; Nitriles; Odds Ratio; Piracetam; Pyridones; Spasms, Infantile; Treatment Outcome; Triazines; Valproic Acid | 2018 |
Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force
Topics: Breast Feeding; Cannabidiol; Carbamazepine; Child; Clobazam; Clonazepam; Epilepsy; Ethosuximide; Everolimus; Felbamate; Female; Fenfluramine; Gabapentin; Humans; Infant; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Prospective Studies; Tiagabine; Topiramate; Valproic Acid; Vigabatrin; Zonisamide | 2022 |
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Topics: Autism Spectrum Disorder; Bromides; Cannabidiol; Clobazam; Cognition; Ethosuximide; Everolimus; Felbamate; Fenfluramine; Humans; Lacosamide; Lamotrigine; Levetiracetam; Pregabalin; Spasms, Infantile; Sulfides; Topiramate; Valproic Acid; Vigabatrin; Zinc Compounds; Zonisamide | 2022 |
Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis.
Topics: Anticonvulsants; Child; Epilepsy, Generalized; Ethosuximide; Humans; Levetiracetam; Network Meta-Analysis; Randomized Controlled Trials as Topic; Seizures; Topiramate; Valproic Acid | 2023 |
40 other study(ies) available for ethosuximide and levetiracetam
| Article | Year |
|---|---|
Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies.
Topics: Amides; Animals; Anticonvulsants; Carbonic Anhydrase II; Cell Line; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Humans; Male; Mice; Rats; Sulfonamides; Thiophenes | 2009 |
Synthesis and anticonvulsant activity of novel 2,6-diketopiperazine derivatives. Part 1: perhydropyrrole[1,2-a]pyrazines.
Topics: Animals; Anticonvulsants; Diketopiperazines; Electroshock; Epilepsy; Humans; Male; Mice; Models, Molecular; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Rats, Wistar; Seizures; Sodium Channel Blockers; Sodium Channels | 2011 |
Synthesis and anticonvulsant activity of new N-Mannich bases derived from 5-cyclopropyl-5-phenyl- and 5-cyclopropyl-5-(4-chlorophenyl)-imidazolidine-2,4-diones.
Topics: Animals; Anticonvulsants; Imidazolidines; Male; Mannich Bases; Mice; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2011 |
Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II.
Topics: Administration, Oral; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroshock; Male; Mannich Bases; Mice; Mice, Inbred Strains; Molecular Structure; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Seizures; Succinimides | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, synthesis and anticonvulsant properties of new N-Mannich bases derived from 3-phenylpyrrolidine-2,5-diones.
Topics: Administration, Oral; Animals; Anticonvulsants; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Disease Models, Animal; Drug Design; Electroshock; Humans; Male; Mannich Bases; Mice; Microsomes, Liver; Motor Activity; Pentylenetetrazole; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Seizures; Structure-Activity Relationship | 2013 |
Structure-activity relationships of the aromatic site in novel anticonvulsant pyrrolo[1,2-a]pyrazine derivatives.
Topics: Animals; Anticonvulsants; Male; Mice; Pyrazines; Pyrroles; Rats; Rats, Sprague-Dawley; Status Epilepticus; Structure-Activity Relationship | 2013 |
Novel fluorinated pyrrolo[1,2-a]pyrazine-2,6-dione derivatives: synthesis and anticonvulsant evaluation in animal models of epilepsy.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Epilepsy; Halogenation; Hydrocarbons, Fluorinated; Male; Mice; Molecular Structure; Pentylenetetrazole; Pilocarpine; Pyrazines; Pyrroles; Rats; Rats, Sprague-Dawley; Seizures; Structure-Activity Relationship | 2014 |
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
Topics: Animals; Anticonvulsants; Cymenes; Disease Models, Animal; Monoterpenes; Phenols; Psychomotor Performance; Seizures; Thymol | 2014 |
Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)propanamides and 2-(2,5-dioxopyrrolidin-1-yl)butanamides.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Electroshock; HEK293 Cells; Humans; Mice; Models, Molecular; Molecular Structure; Motor Activity; Piperazines; Seizures; Structure-Activity Relationship; Succinimides | 2015 |
New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
Topics: Analgesics; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Injections, Intraperitoneal; Mice; Molecular Structure; Pain; Pain Measurement; Pentylenetetrazole; Piperazines; Pyrrolidinones; Seizures | 2016 |
Synthesis, and anticonvulsant activity of new amides derived from 3-methyl- or 3-ethyl-3-methyl-2,5-dioxo-pyrrolidin-1-yl-acetic acids.
Topics: Amides; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Molecular Structure; Pentylenetetrazole; Pyrrolidines; Seizures | 2016 |
Synthesis and evaluation of anticonvulsant properties of new N-Mannich bases derived from 3-(1-phenylethyl)- and 3-benzyl-pyrrolidine-2,5-dione.
Topics: Animals; Anticonvulsants; Calcium Channel Blockers; Calcium Channels, L-Type; GABA-A Receptor Antagonists; Mannich Bases; Mice; Piperazines; Pyrrolidines; Receptors, N-Methyl-D-Aspartate; Sodium Channel Blockers; Structure-Activity Relationship; Succinimides | 2016 |
Design, synthesis and anticonvulsant activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and -butanamides.
Topics: Amides; Animals; Anticonvulsants; Calcium Channels; Drug Design; Humans; Injections, Intraperitoneal; Mice; Molecular Structure; Neurons; Pyrrolidines; Seizures | 2016 |
Synthesis and evaluation of anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl-, 3-isopropyl, and 3-benzhydryl analogs.
Topics: Animals; Anticonvulsants; Mannich Bases; Mice; Pyrrolidines; Seizures | 2017 |
Modulating the Serotonin Receptor Spectrum of Pulicatin Natural Products.
Topics: Animals; Biological Products; Ligands; Mice; Molecular Structure; Receptors, Serotonin; Structure-Activity Relationship; Thiazolidines | 2017 |
Topographic approaches in human quantitative pharmaco-electroencephalography.
Topics: Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Electroencephalography; Ethosuximide; Evoked Potentials; Flurazepam; Humans; Levetiracetam; Piracetam; Psychotropic Drugs; Valproic Acid | 1983 |
Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation.
Topics: Acetates; Amines; Animals; Anticonvulsants; Carbamates; Carbamazepine; Cell Death; Cells, Cultured; Chlordiazepoxide; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Ethosuximide; Felbamate; Gabapentin; gamma-Aminobutyric Acid; Glucose; Hippocampus; Hypoxia; Ischemia; Lamotrigine; Levetiracetam; Midazolam; Neurons; Neuroprotective Agents; Nipecotic Acids; Oxcarbazepine; Phenobarbital; Phenylcarbamates; Phenylenediamines; Phenytoin; Piracetam; Propylene Glycols; Rats; Rats, Wistar; Tiagabine; Triazines; Valproic Acid | 2003 |
Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report.
Topics: Anticonvulsants; Behavior; Child, Preschool; Electroencephalography; Electromyography; Epilepsies, Myoclonic; Ethosuximide; Humans; Levetiracetam; Male; Piracetam; Status Epilepticus | 2006 |
Juvenile myoclonic epilepsy: a benign disorder? Personality traits and psychiatric symptoms.
Topics: Adolescent; Adult; Anticonvulsants; Child; Ethosuximide; Female; Fructose; Humans; Lamotrigine; Levetiracetam; Male; Mental Disorders; Myoclonic Epilepsy, Juvenile; Personality; Personality Tests; Piracetam; Psychiatric Status Rating Scales; Surveys and Questionnaires; Topiramate; Triazines; Valproic Acid | 2007 |
Levetiracetam attenuates spontaneous spike-and-wave discharges in DBA/2J mice.
Topics: Animals; Anticonvulsants; Electroencephalography; Epilepsy, Absence; Ethosuximide; Injections, Intraperitoneal; Levetiracetam; Male; Mice; Mice, Inbred DBA; Piracetam; Valproic Acid | 2007 |
Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia.
Topics: Age of Onset; Anticonvulsants; Child; Cognition Disorders; Dietary Fats; Electroencephalography; Epilepsies, Myoclonic; Ethosuximide; Female; Hospitals, Pediatric; Humans; Ketones; Ketosis; Lamotrigine; Levetiracetam; Male; Pennsylvania; Piracetam; Retrospective Studies; Survival Analysis; Syndrome; Triazines | 2007 |
Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model.
Topics: Animals; Anticonvulsants; Clonazepam; Convulsants; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Ethosuximide; Levetiracetam; Male; Mice; Pentylenetetrazole; Phenobarbital; Piracetam; Seizures; Valproic Acid | 2009 |
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy.
Topics: Age Factors; Analysis of Variance; Animals; Anticonvulsants; Chromatography, High Pressure Liquid; Disease Models, Animal; Epilepsy, Absence; Ethosuximide; Levetiracetam; Male; Piracetam; Rats; Rats, Mutant Strains; Time Factors | 2010 |
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Depression; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Absence; Ethosuximide; Isoxazoles; Levetiracetam; Male; Piracetam; Rats; Rats, Wistar; Seizures; Zonisamide | 2011 |
Early-onset childhood absence epilepsy: is it a distinct entity?
Topics: Age Factors; Age of Onset; Anticonvulsants; Child; Child Development; Child, Preschool; Cohort Studies; Disease Progression; Drug Therapy, Combination; Electroencephalography; Epilepsy, Absence; Ethosuximide; Female; Follow-Up Studies; Humans; Lamotrigine; Language Development Disorders; Levetiracetam; Male; Piracetam; Prognosis; Prospective Studies; Sex Factors; Treatment Outcome; Triazines | 2011 |
[Transitory cognitive dysfunction in rolandic epilepsy].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Cognition Disorders; Drug Therapy, Combination; Epilepsy, Rolandic; Ethosuximide; Female; Humans; Levetiracetam; Male; Piracetam; Recovery of Function; Remission Induction; Valproic Acid | 2011 |
A rat model for LGI1-related epilepsies.
Topics: Amino Acid Sequence; Animals; Anticonvulsants; Brain; Carbamazepine; Cells, Cultured; Chlorocebus aethiops; COS Cells; Disease Models, Animal; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Reflex; Ethosuximide; Heterozygote; Homozygote; Humans; Intercellular Signaling Peptides and Proteins; Levetiracetam; Molecular Sequence Data; Mutation, Missense; Neurons; Phenytoin; Piracetam; Proteins; Rats, Mutant Strains | 2012 |
[Idiopathic focal epilepsies of infancy and childhood].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Epilepsy, Rolandic; Ethosuximide; Female; Humans; Infant; Levetiracetam; Male; Piracetam; Valproic Acid | 2011 |
[Epilepsies with electric status epilepticus in sleep: peculiarities of clinical course and rational approaches to treatment].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistance; Electricity; Electroencephalography; Ethosuximide; Female; Humans; Levetiracetam; Male; Piracetam; Sleep Stages; Sleep Wake Disorders; Status Epilepticus; Syndrome; Valproic Acid | 2011 |
Teratogenic potential of antiepileptic drugs in the zebrafish model.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Ethosuximide; Female; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Piracetam; Pregnancy; Teratogenesis; Topiramate; Triazines; United States; Valproic Acid; Zebrafish | 2013 |
Zebrafish embryotoxicity test for developmental (neuro)toxicity: Demo case of an integrated screening approach system using anti-epileptic drugs.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Dose-Response Relationship, Drug; Endpoint Determination; Ethosuximide; In Situ Hybridization; Levetiracetam; Piracetam; Toxicity Tests; Valproic Acid; Zebrafish | 2014 |
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary.
Topics: Animals; Anticonvulsants; Behavior, Animal; Depression; Disease Models, Animal; Duration of Therapy; Epilepsy, Absence; Ethosuximide; Levetiracetam; Male; Motor Activity; Rats; Rats, Inbred Strains; Seizures; Time Factors | 2019 |
N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug.
Topics: Animals; Anticonvulsants; Behavior, Animal; Dose-Response Relationship, Drug; Epilepsy; Ethosuximide; Lacosamide; Levetiracetam; Male; Mice; Pentylenetetrazole; Pyrrolidines; Seizures; Valproic Acid; Zebrafish | 2020 |
Evaluation of the impact of compound C11 a new anticonvulsant candidate on cognitive functions and hippocampal neurogenesis in mouse brain.
Topics: Animals; Anticonvulsants; Brain; Cognition; Epilepsy; Ethosuximide; Hippocampus; Lacosamide; Levetiracetam; Male; Mice; Mice, Inbred C57BL; Neurogenesis; Pentylenetetrazole; Spatial Memory | 2020 |
Response of spike-wave discharges in aged APP/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs.
Topics: 3-Hydroxybutyric Acid; Action Potentials; Alzheimer Disease; Animals; Anticonvulsants; Atropine; Disease Models, Animal; Donepezil; Drug Administration Schedule; Electroencephalography; Epilepsy; Ethosuximide; GABA Antagonists; Humans; Injections, Intraperitoneal; Lactic Acid; Levetiracetam; Male; Mice; Mice, Transgenic; Nootropic Agents; Organophosphorus Compounds; Parasympatholytics; Plaque, Amyloid; Pyruvic Acid; Video Recording | 2020 |
Effects of antiseizure monotherapy on visuospatial memory in pediatric age.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Ethosuximide; Executive Function; Female; Humans; Levetiracetam; Longitudinal Studies; Male; Neuropsychological Tests; Retrospective Studies; Spatial Memory; Valproic Acid | 2021 |
Pharmacotherapeutic management of seizures in patients with Angleman Syndrome.
Topics: Anticonvulsants; Cannabidiol; Child; Clobazam; Clonazepam; Ethosuximide; Humans; Lamotrigine; Levetiracetam; Quality of Life; Seizures; Topiramate; Valproic Acid | 2022 |
[Epilepsy in Angelman syndrome].
Topics: Angelman Syndrome; Anticonvulsants; Child; Electroencephalography; Epilepsy; Ethosuximide; Female; Humans; Levetiracetam; Male; Seizures; Valproic Acid | 2022 |